CBN

1. 2026-10-19issueIssued emergency
2. 2026-10-19issueIssued info_card
3. 2026-09-07srcThe early history of cannabinoid research
4. 2026-09-07srcChemical diversity, receptor binding affinity, and pharmacology of phytocannabinoids: Insights into neuronal mechanisms.
5. 2026-09-07srcCannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma.
6. 2026-09-07srcImpact of minor cannabinoids on key pharmacological targets of estrogen receptor-positive breast cancer.
7. 2026-09-07srcSpecies differences in pregnane X receptor activation by delta-9-tetrahydrocannabinol, cannabidiol, and cannabinol
8. 2026-09-07srcCannabichromene from full-spectrum hemp extract exerts acute anti-seizure effects through allosteric activation of GABAA receptors.
9. 2026-09-07srcAntiepileptic activity and potential mechanism of full-spectrum hemp extract.
10. 2026-09-07srcDifferences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures.
11. 2026-09-07srcEvaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.
12. 2026-09-07srcHepatic biotransformation of non-psychotropic phytocannabinoids and activity screening on cytochromes P450 and UDP-glucuronosyltransferases.
13. 2026-09-07srcAntibacterial cannabinoids from Cannabis sativa: a structure-activity study.
14. 2026-09-07srcPhytocannabinoids: a unified critical inventory
15. 2026-09-07srcCannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.
16. 2026-09-07srcCannabinol and Sleep: Separating Fact from Fiction.
17. 2026-09-07srcThe anti-biofilm activity of cannabinoids against methicillin-resistant Staphylococcus aureus.
18. 2026-09-07srcEffects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
19. 2026-09-07srcCannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial.
20. 2026-09-07srcThe effects of subacute exposure to a water-soluble cannabinol compound in male mice.
21. 2026-09-07srcNonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
22. 2026-09-07srcExogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review.
23. 2026-09-07srcMinor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
24. 2026-09-07srcCannabis sativa: The Plant of the Thousand and One Molecules
25. 2026-09-07srcA critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids
26. 2026-09-07srcCannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells.
27. 2026-09-07srcThe Anticancer Activity of Cannabinol (CBN) and Cannabigerol (CBG) on Acute Myeloid Leukemia Cells.
28. 2026-09-07srcAP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun.
29. 2026-09-07srcCannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity.
30. 2026-09-07srcAttenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice.
31. 2026-09-07srcPharmacokinetics of cannabinoids
32. 2026-09-07srcSimultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
33. 2026-09-07srcThe effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
34. 2026-09-07srcMeta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences.
35. 2026-09-07srcThe multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids.
36. 2026-09-07srcCannabinol (CID 2543)
37. 2026-09-07srcCannabinoids in glaucoma: a primary screening procedure.
38. 2026-09-07srcEvaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
39. 2026-09-07srcCBN legal status United States, UK, Australia, Europe 2026
40. 2026-09-07srcCBN psychoactive effects humans - Perez-Reyes 1973 and Hollister 1973 review
41. 2026-09-07srcINM-755 Phase 2 Clinical Trial Results - Epidermolysis Bullosa
42. 2026-09-07srcCBN first isolation 1896 - Wood, Spivey, Easterfield history
43. 2026-09-04issueIssued emergency
44. 2026-09-04issueIssued info_card
45. 2026-09-04issueIssued notice
46. 2026-06-04proposal17 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
47. 2026-06-04publicationPublication — backfill
48. 2026-05-07revisionRevision 1
49. 2026-05-07genGeneration — pipeline-v5 · with 2 morepipeline-v5
50. 2026-05-07rungeneration run

The same entries, as forms: six forms.